Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer

Gynecologic Oncology

Volumn 114, Issue 2, 2009, Pages 260-264

  Peedicayil, Abraham ^a   Vierkant, Robert A ^a   Shridhar, Vijayalakshmi ^a   Schildkraut, Joellen M ^b   Armasu, Sebastian ^a   Hartmann, Lynn C ^a   Fridley, Brooke L ^a   Cunningham, Julie M ^a   Phelan, Catherine M ^c   Sellers, Thomas A ^c   Goode, Ellen L ^a  

^a Mayo Clinic College of Medicine   (United States)

^b DUKE UNIVERSITY   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Polymorphism

Indexed keywords

TRANSCRIPTION ELONGATION FACTOR; TRANSCRIPTION FACTOR TCEAL7; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENOTYPE; HAPLOTYPE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 67549098087     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.03.038     Document Type: Article

References (26)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 2 (2005) 74-108
2. Ramus S.J., Harrington P.A., Pye C., DiCioccio R.A., Cox M.J., Garlinghouse-Jones K., et al. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Hum. Mutat. 28 12 (2007) 1207-1215
3. Cox A., Dunning A.M., Garcia-Closas M., Balasubramanian S., Reed M.W., Pooley K.A., et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 39 3 (2007) 352-358
4. Chien J., Staub J., Avula R., Zhang H., Liu W., Hartmann L.C., et al. Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer. Oncogene 24 32 (2005) 5089-5100
5. Brown A.L., and Kay G.F. Bex1, a gene with increased expression in parthenogenetic embryos, is a member of a novel gene family on the mouse X chromosome. Hum. Mol. Genet. 8 4 (1999) 611-619
6. Chien J., Narita K., Rattan R., Giri S., Shridhar R., and Staub J. A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation. Oncogene (2008)
7. Mukai J., Hachiya T., Shoji-Hoshino S., Kimura M.T., Nadano D., Suvanto P., et al. NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR. J. Biol. Chem. 275 23 (2000) 17566-17570
8. Sellers T.A., Schildkraut J.M., Pankratz V.S., Vierkant R.A., Fredericksen Z.S., Olson J.E., et al. Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 14 11 Pt 1 (2005) 2536-2543
9. Cunningham J.M., Sellers T.A., Schildkraut J.M., Fredericksen Z.S., Vierkant R.A., Kelemen L.E., et al. Performance of amplified DNA in an Illumina GoldenGate BeadArray assay. Cancer Epidemiol. Biomarkers Prev. 17 7 (2008) 1781-1789
10. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 7164 (2007) 851-861
11. Kathiresan S., Voight B.F., Purcell S., Musunuru K., Ardissino D., Mannucci P.M., et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. (2009)
12. Eeles R.A., Kote-Jarai Z., Giles G.G., Olama A.A., Guy M., Jugurnauth S.K., et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 40 3 (2008) 316-321
13. Hinds D.A., Stuve L.L., Nilsen G.B., Halperin E., Eskin E., Ballinger D.G., et al. Whole-genome patterns of common DNA variation in three human populations. Science 307 5712 (2005) 1072-1079
14. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., and Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74 1 (2004) 106-120
15. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. BioTechniques 2002;Suppl:56-8, 60-1.
16. Sellers T.A., Huang Y., Cunningham J., Goode E.L., Sutphen R., Vierkant R.A., et al. Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 17 2 (2008) 397-404
17. Kelemen L.E., Sellers T.A., Schildkraut J.M., Cunningham J.M., Vierkant R.A., Pankratz V.S., et al. Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res. 68 7 (2008) 2498-2506
18. Weir B.S. Genetic data analysis II: methods for discrete population genetic data (1996), Sinauer Associates, Inc., Sunderland MA
19. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 2 (2005) 263-265
20. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70 2 (2002) 425-434
21. D'Andrilli G., Giordano A., and Bovicelli A. Epithelial ovarian cancer: the role of cell cycle genes in the different histotypes. Open Clin. Cancer J. 2 (2008) 7-12
22. Pearce C.L., Near A.M., Van Den Berg D.J., Ramus S.J., Gentry-Maharaj A., Menon U., et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br. J. Cancer 100 2 (2009) 412-420
23. Ramus S.J., Vierkant R.A., Johnatty S.E., Pike M.C., Van Den Berg D.J., Wu A.H., et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. Intl. J. Cancer 123 2 (2008) 380-388
24. Song H., Koessler T., Ahmed S., Ramus S.J., Kjaer S.K., Dicioccio R.A., et al. Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer. Cancer Res. 68 21 (2008) 8837-8842
25. Mayr D., Kanitz V., Amann G., Engel J., Burges A., Lohrs U., et al. HER-2/neu gene amplification in ovarian tumours: a comprehensive immunohistochemical and FISH analysis on tissue microarrays. Histopathology 48 2 (2006) 149-156
26. Pearce C.L., Wu A.H., Gayther S.A., Bale A.E., Beck P.A., Beesley J., et al. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis. Br. J. Cancer 98 2 (2008) 282-288